Research published in Science Advances indicates that CVXGA is a promising intranasal vaccine candidate that is safe, immunogenic and potentially effective ...

Researchers at DTU Biosustain (The Novo Nordisk Foundation Center for Biosustainability at DTU) have developed a new tool ...

New drugs that target 'zombie' tuberculosis (TB) cells are now a step closer, thanks to a new study led by the University of ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating t ...

Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 ... Unity Biotechnology, Inc. UBX stock plummeted on Monday after the company released results from its ...

Shares of Vir Biotechnology VIR plunged 44.90% after the company announced that the mid-stage PENINSULA (PrevEntioN of IllNesS DUe to InfLuenza A) study evaluating VIR-2482 for the prevention of ...

A study released in December of 2024 has found that drones not only can provide rural residents with access to healthcare resources, but that rural people are eager to embrace the new technology.

Shares of Sana Biotechnology jumped after the company reported positive results for the latest study transplanting its UP421 cell therapy into a patient with type 1 diabetes. The stock was up 21% at ...

Our BSc Biotechnology with Entrepreneurship degree enables you to improve your business innovation skills and spend a year on placement. ... Study abroad. Industry placements are available at home and ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced 24-week post-end of treatment data from Part B of the ongoing MARCH Phase 2 clinical study evaluating tobevibart and elebsiran without or with ...